<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02375568</url>
  </required_header>
  <id_info>
    <org_study_id>201405EMO</org_study_id>
    <nct_id>NCT02375568</nct_id>
  </id_info>
  <brief_title>Large-scale Expansion and Characterization of Mesenchymal Stem Cells for Clinical Application</brief_title>
  <official_title>Large-scale ex Vivo Expansion and Characterization of Synovial Membrane Mesenchymal Stem Cells (SM-MSC) and Infrapatellar Fat Pad Mesenchymal Stem Cells (IF-MSC) for Clinical Application</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Chin-Hung Chang</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>EMO Biomedicine Corporation</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Far Eastern Memorial Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      According to many recent research, mesenchymal stem cells (MSC) isolated from synovial
      membrane and infrapatellar fat pad have higher ex vivo proliferation capacity, multipotency
      and ability to undergo chondrogenesis.

      Based on this concept, the investigators plan to get two removed tissues (synovial membrane
      and infrapatellar fat pad) from patients who have an operation of total knee replacement. The
      investigators are going to isolate and expand MSC from these two tissues respectively, and
      then compare the chondrogenesis ability for clinical application. In the other hand, the
      investigators plan to build techniques and procedures which comply with &quot;Good Tissue
      Practices (GTP)&quot;
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>May 2014</start_date>
  <completion_date type="Anticipated">August 2015</completion_date>
  <primary_completion_date type="Anticipated">August 2015</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Cell viability ratio of synovial membrane MSC and infrapatellar fat pad MSC from the first to the tenth cell passage</measure>
    <time_frame>6 months</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Doubling time of synovial membrane MSC and infrapatellar fat pad MSC from the first to the tenth cell passage</measure>
    <time_frame>6 months</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Percentage expression of cluster differentiation 90,105, 34, 45 surface markers of synovial membrane MSC and infrapatellar fat pad MSC from the first to the tenth cell passage</measure>
    <time_frame>6 months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Alcian blue staining of synovial membrane MSC and infrapatellar fat pad MSC</measure>
    <time_frame>6 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Tyep II collagen and aggrecan gene expression of synovial membrane MSC and infrapatellar fat pad MSC</measure>
    <time_frame>6 months</time_frame>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">6</enrollment>
  <condition>Knee Injuries</condition>
  <arm_group>
    <arm_group_label>103024-F</arm_group_label>
    <description>For patients who have an operation of total knee replacement, two removed tissues (synovial membrane and infrapatellar fat pad) will be collected for mesenchymal stem cell isolation.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>103024-F</intervention_name>
    <description>mesenchymal stem cell isolation</description>
    <arm_group_label>103024-F</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patient who have an total knee replacement surgery
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

        Patient who have an total knee replacement surgery

        Exclusion Criteria:

        Patient who don't sign the agreement
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Chih-Hung Chang, MD, Ph.D</last_name>
    <phone>886-2-89667000</phone>
    <phone_ext>2888</phone_ext>
    <email>orthocch@mail.femh.org.tw</email>
  </overall_contact>
  <location>
    <facility>
      <name>Far Eastern Memorial Hospital</name>
      <address>
        <city>Pan-Ciao</city>
        <state>Taipei</state>
        <zip>220</zip>
        <country>Taiwan</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Chih-Hung Chang, Ph. D</last_name>
      <phone>886-2-89667000</phone>
      <phone_ext>2888</phone_ext>
      <email>orthocch@mail.femh.org.tw</email>
    </contact>
  </location>
  <location_countries>
    <country>Taiwan</country>
  </location_countries>
  <verification_date>February 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 10, 2015</study_first_submitted>
  <study_first_submitted_qc>February 24, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 2, 2015</study_first_posted>
  <last_update_submitted>February 24, 2015</last_update_submitted>
  <last_update_submitted_qc>February 24, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">March 2, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Far Eastern Memorial Hospital</investigator_affiliation>
    <investigator_full_name>Chin-Hung Chang</investigator_full_name>
    <investigator_title>MD. PhD.</investigator_title>
  </responsible_party>
  <keyword>mesenchymal stem cells</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Knee Injuries</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

